DNLI
Price
$18.00
Change
+$0.84 (+4.90%)
Updated
Nov 21 closing price
Capitalization
2.64B
100 days until earnings call
Intraday BUY SELL Signals
NRSN
Price
$1.10
Change
+$0.03 (+2.80%)
Updated
Nov 21 closing price
Capitalization
32.51M
4 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNLI vs NRSN

Header iconDNLI vs NRSN Comparison
Open Charts DNLI vs NRSNBanner chart's image
Denali Therapeutics
Price$18.00
Change+$0.84 (+4.90%)
Volume$1.45M
Capitalization2.64B
NeuroSense Therapeutics
Price$1.10
Change+$0.03 (+2.80%)
Volume$244.04K
Capitalization32.51M
DNLI vs NRSN Comparison Chart in %
DNLI
Daily Signal:
Gain/Loss:
NRSN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DNLI vs. NRSN commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and NRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (DNLI: $18.00 vs. NRSN: $1.10)
Brand notoriety: DNLI and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 82% vs. NRSN: 94%
Market capitalization -- DNLI: $2.64B vs. NRSN: $32.51M
DNLI [@Biotechnology] is valued at $2.64B. NRSN’s [@Biotechnology] market capitalization is $32.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, DNLI is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 6 TA indicator(s) are bullish while NRSN’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 6 bullish, 4 bearish.
  • NRSN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than NRSN.

Price Growth

DNLI (@Biotechnology) experienced а +3.18% price change this week, while NRSN (@Biotechnology) price change was +11.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 02, 2026.

NRSN is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.64B) has a higher market cap than NRSN($32.5M). NRSN YTD gains are higher at: -8.333 vs. DNLI (-11.703). NRSN has higher annual earnings (EBITDA): -8.55M vs. DNLI (-521.52M). DNLI has more cash in the bank: 899M vs. NRSN (666K). NRSN has less debt than DNLI: NRSN (19K) vs DNLI (46.6M). DNLI (0) and NRSN (0) have equivalent revenues.
DNLINRSNDNLI / NRSN
Capitalization2.64B32.5M8,120%
EBITDA-521.52M-8.55M6,099%
Gain YTD-11.703-8.333140%
P/E RatioN/AN/A-
Revenue00-
Total Cash899M666K134,985%
Total Debt46.6M19K245,263%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLINRSN
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signal:
Gain/Loss:
NRSN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIF72.513.18
+4.59%
Life360 Inc Common Stock
GSL33.540.40
+1.19%
Global Ship Lease
ETN331.713.52
+1.07%
Eaton Corp
BRY3.300.02
+0.46%
Berry Corp
NOTE2.00-0.01
-0.50%
FiscalNote Holdings

NRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRSN has been loosely correlated with NEVPF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NRSN jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+2.80%
NEVPF - NRSN
49%
Loosely correlated
N/A
PBM - NRSN
40%
Loosely correlated
-13.37%
SLRX - NRSN
32%
Poorly correlated
+16.02%
CTMX - NRSN
31%
Poorly correlated
+3.18%
DNLI - NRSN
29%
Poorly correlated
+4.87%
More